Skip to main content

Cardio-oncology Related to Heart Failure, An Issue of Heart Failure Clinics

  • 1st Edition, Volume 7-3 - July 28, 2011
  • Authors: Daniel J. Lenihan, Douglas B. Sawyer
  • Language: English
  • Hardback ISBN:
    9 7 8 - 1 - 4 5 5 7 - 1 1 0 1 - 7

As the number of effective anti-neoplastic agents has grown, there has been a concomitant increase in side effects.  Cardiotoxicity, and specifically LV dysfunction, remains the… Read more

Purchase options

BACK-TO-SCHOOL

Fuel your confidence!

Up to 25% off learning resources

Elsevier academics book covers
As the number of effective anti-neoplastic agents has grown, there has been a concomitant increase in side effects. Cardiotoxicity, and specifically LV dysfunction, remains the limiting factor for many such agents, and is the focus of growing research and clinical emphasis. This issue summarizes for the heart failure specialist the possible ways that chemotherapeutic agents might cause cardiotoxicity as well as the methods for detecting, treating and preventing cardiotoxicity.

Related books